Cutaneous lupus erythematosus is a chronic autoimmune disease with few treatment options and no approved targeted therapies.

Metabolic syndrome is associated with a greater risk for excessive scarring, with several specific metabolic components linked to higher risk.

While no association was observed between use of biologics and incident PsA overall, specific biologic classes were ...

Skyrizi (risankizumab-rzaa) IL-23 inhibitor Treatment of children aged 6 years and older with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy, and for ...

Bemotrizinol, recently approved as a new active ingredient in sunscreens, is the first new ingredient for OTC sunscreen ...

Pregnancy may not be a risk factor for invasive melanoma or melanoma in situ, though women of reproductive age may be at an increased risk.

Whereas both dosing regimens of abrocitinib were effective among patients with atopic dermatitis, continuous treatment with abrocitinib 200 mg was associated with greater efficacy rates than variable ...

The addition of microneedling to topical minoxidil for the treatment of women with androgenetic alopecia provides no ...

Researchers studied the relationship between dermatologist density and the proportion of late-stage melanoma diagnoses.

Researchers studied the effectiveness of a food supplement on improving hair density among patients with non-illness-related hair thinning and loss.

Among patients with psoriasis or atopic dermatitis who had phenotype switching, Janus kinase inhibitors were the most commonly used treatments for therapy modification. Treatment-associated phenotype ...

Rheumatoid factor may be associated with more significant disease burden and less response to treatment in patients with PsA.